Evidence map›Paper›PMID 41575207›Full record

ArticleApplied and environmental microbiology2026

Inactivation of airborne pathogen surrogates by triethylene glycol.

Grishma Desai, Emanuel Goldman, William Jordan, Jamie Balarashti, Jack Caravanos, Rachel Edgar, Etienne Grignard, Gurumurthy Ramachandran, Gediminas Mainelis

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Grishma DesaiGrignard Company, LLC, Rahway, New Jersey, USA.ORCID 0000-0002-1163-8400
Emanuel GoldmanDepartment of Microbiology, Biochemistry, and Molecular Genetics, Rutgers New Jersey Medical School, Newark, New Jersey, USA.ORCID 0000-0002-6748-0884
William JordanOffice of Pesticide Programs, Environmental Protection Agency, Washington, DC, USA.
Jamie BalarashtiAerosol Research and Engineering Labs, Overland Park, Kansas, USA.
Jack CaravanosClinical Professor of Environmental Public Health Services, New York University, New York, New York, USA.
Rachel EdgarDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Etienne GrignardBleu Garde, LLC, Rahway, New Jersey, USA.
Gurumurthy RamachandranDepartment of Environmental Health and Engineering, Johns Hopkins Education and Research Center for Occupational Safety and Health, Bloomberg School of Public Health, Whiting School of Engineering, The Johns Hopkins University, Baltimore, Maryland, USA.
Gediminas MainelisDepartment of Environmental Sciences, School of Environmental and Biological Sciences, Rutgers, The State University of NJ, New Brunswick, New Jersey, USA.ORCID 0000-0002-5837-0413

Funding

Bleu Garde, LLCNew Jersey Health Foundation PC104-25NIEHS NIH HHS P30 ES05022Royal Society-Wellcome Sir Henry Dale Fellowship 208790/Z/17/ZUKRI Future Leaders Fellowship MR/Y017552/1U.S. Department of Agriculture 1025241
6 · The paper itself

Abstract

The COVID-19 outbreak brought to the fore the importance of airborne transmission in spreading human infectious diseases and highlighted the need for sustainable mitigation strategies. Triethylene glycol (TEG) has been documented as having microbicidal capabilities and has been proposed as one such mitigation strategy. Aerosolized TEG exhibits antimicrobial activity against airborne microorganisms. Grignard Pure Technology was developed to safely aerosolize TEG for decontamination of enclosed spaces. Here, we show that this TEG formulation effectively inactivates airborne microorganisms, resulting in 2 to 4.5 net log reduction in concentration of viable bacteria, viruses, and mycobacteria within 30-60 min at TEG concentration (aerosol + vapor) of ~0.7 mg/m

Indexed as

Air MicrobiologyBacteriaDisinfectantsPolyethylene GlycolsAerosolsCOVID-19DisinfectionHumansMycobacteriumPandemicsSARS-CoV-2VirusesAerosolsDisinfectantsPolyethylene Glycolstriethylene glycolaerosolized antimicrobialsairborne transmissionantimicrobial efficacysurrogate microorganismstriethylene glycol

Identifiers

PMID41575207
PMCPMC12915340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.